Furthermore, administration of COX-2 inhibitors in conjunction with anti-programmed death ligand-1 (α-PD-L1) therapy can fully suppress metastatic tumor growth, effectively transforming “cold tumors” into “hot tumors” [48,49]. This evidence concerns the gene PTGS2 and neoplasm.